Ignite Creation Date:
2024-05-06 @ 8:27 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02747108
Status:
COMPLETED
Last Update Posted:
2023-07-25
First Post:
2016-04-18
Brief Title:
ForgIng New Paths to Prevent DIabeTes FINDIT
Sponsor:
VA Office of Research and Development
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Improving Veteran Engagement in Diabetes Prevention CDA 13-267
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FINDIT
Brief Summary:
This study will evaluate the effects of screening for type 2 diabetes mellitus T2DM and brief counseling about screening test results on weight and key health behaviors among Veterans with risk factors for T2DM Study participants will be randomly assigned to one of two study groups 1 Blood Test Group or 2 Brochure Group Participants in the Blood Test Group will complete a blood test called hemoglobin A1c HbA1c which measures average blood sugar levels Participants will receive brief counseling about the results from their primary care provider or someone authorized to speak on their behalf Participants randomly selected for the Brochure Group will review a handout from the VA National Center for Health Promotion and Disease Prevention NCP on recommended screening tests and immunizations All participants will be asked to complete a survey prior to study group assignment immediately after a Primary Care appointment 3 months after enrollment and 12 months after enrollment
Detailed Description:
An essential step in designing effective strategies to improve patient engagement in behavior change is to better understand their current levels of engagement in these behaviors and determine which factors most influence their engagement Within and outside the Veterans Health Administration VHA little is known about how patients with risk factors for T2DM view their risk of developing T2DM what these patients understand about strategies to reduce this risk and to what degree at-risk patients are currently engaging in behaviors to prevent T2DM This project will generate important new data in these areas and will improve the investigators understanding of the effects of a prediabetes diagnosis and brief counseling on engagement in behaviors to prevent T2DM and mediators of these behaviors
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CDA 13-267 | OTHER_GRANT | VA Health Services Research and Development | None |